These medications have been associated with a 40 percent reduction in opioid overdose and 50 percent lower rate of alcohol intoxication.

We're living in the era of Ozempic. For others, however, the accessibility has led to misuse. "We have a little bit of a wild west in who's writing for this medication now, because it is so ...

Ozempic and similar licensed weight loss drugs have exploded in popularity in recent years, with polls showing that as many as one in eight American adults have tried this class of medication at ...

The sky continues to be the limit for semaglutide, the active ingredient in popular drugs Ozempic and Wegovy. Newly published research is the latest to suggest that semaglutide and other GLP-1 ...

People who want to be teeny-tiny are taking a pint-sized shot of Ozempic. “Microdosing” the weight-loss drug is becoming increasingly common, according to doctors — and it’s not always a ...

Ozempic does not cause excessive weight loss in the face. But, if someone loses a lot of weight in a short amount of time, most often when they weren’t overweight or obese to begin with, they ...

A new study has found that users of Ozempic or a similar drug had a 40% lower rate of opioid overdose and a 50% lower rate of alcohol intoxication than those without a prescription. Fernanda ...

Should we call him… Skinny Joe? Fat Joe confessed to using Ozempic after shedding a whopping 200 pounds in recent years. The “All the Way Up” rapper credited the Type 2 diabetes drug ...

The large study analyzed the health records of 1.3 million people. A new study suggests that GLP-1 agonist medications like Ozempic, which are used for diabetes management and weight loss, may ...

skimming sales racks or even sweeping one’s own closet is now a new kind of challenge for many of the estimated 15.5 million Americans on Ozempic, Wegovy and their fat-zapping kin. In fact ...

The best known of these drugs is Ozempic, a medication for diabetes often prescribed for its off-label use as a weight loss aid. A new study published in the journal Addiction on October 16 ...